• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[2008年至2022年期间,马德里地区一家二级公立医院中引起侵袭性肺炎球菌疾病的血清型演变情况,及其与不同结合疫苗纳入情况的关系]

[Evolution of the serotypes causing invasive pneumococcal disease along 2008-2022 in a Level 2 Public Hospital of the Madrid Region, in relation to their inclusion in different conjugate vaccines].

作者信息

Zaragoza Vargas G, Cacho Calvo J, Martínez-Arce R, Molina Arana D, Ramos Blázquez B, Pérez Abeledo M, Sanz Moreno J C

机构信息

Gloria Zaragoza Vargas, Servicio de Microbiología. Hospital Universitario de Getafe (Getafe, Madrid)

出版信息

Rev Esp Quimioter. 2023 Dec;36(6):597-603. doi: 10.37201/req/034.2023. Epub 2023 Oct 24.

DOI:10.37201/req/034.2023
PMID:37873744
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10710669/
Abstract

OBJECTIVE

The use of conjugate vaccines against Streptococcus pneumoniae originates changes in the invasive pneumococcal disease (IPD). The aim of this study was to in vestigate the evolution of S. pneumoniae serotypes isolated in the Hospital Universitario de Getafe between 2008 and 2022.

METHODS

313 of S. pneumoniae strains were studied. Serotyping was carried out by latex agglutination (Pneumotest-latex) and the Quellung reaction. In addition, the minimal inhibitory concentration (MIC) was determined against penicillin, erythromycin and levofloxacin by the concentration gradient method (E-test) according the EUCAST breakpoints.

RESULTS

The most frequent serotypes throughout the study period were 8, 3, 19A, 1, 11A and 22F corresponding to 46.6% of the isolates. Along 2008-2012 the serotypes 3, 1, 19A, 7F, 6C and 11A represented altogether 53.6% of the isolates. Between 2013 and 2017 the serotypes 3, 8, 12F, 19A, 22F and 19F grouped 51% of the isolates. During 2018-2022 the serotypes 8, 3, 11A, 15A, 4 and 6C included the 55.5% of the cases. In total 5 strains (1.6%) were penicillin resistant, 64 (20.4%) erythromycin resistant and 11 (3.5%) levofloxacin resistant. The MIC50 and MIC90 levels maintained stables along the time.

CONCLUSIONS

The conjugate vaccines use with different serotype coverage conditioned a decrease of the vaccine-included and an increase of non-covered. Despite these changes, the global antimicrobial susceptibility patterns to erythromycin and levofloxacin maintained relatively stables. The resistance a penicillin was low, not finding this type of resistant strains in the last study period.

摘要

目的

使用针对肺炎链球菌的结合疫苗引发了侵袭性肺炎球菌疾病(IPD)的变化。本研究的目的是调查2008年至2022年期间在赫塔费大学医院分离出的肺炎链球菌血清型的演变情况。

方法

对313株肺炎链球菌菌株进行了研究。通过乳胶凝集试验(肺炎球菌检测乳胶)和荚膜肿胀反应进行血清分型。此外,根据欧盟药敏试验委员会(EUCAST)的断点,采用浓度梯度法(E试验)测定了对青霉素、红霉素和左氧氟沙星的最低抑菌浓度(MIC)。

结果

在整个研究期间,最常见的血清型为8型、3型、19A 型、1型、11A 型和22F型,占分离株的46.6%。在2008 - 2012年期间,3型、1型、19A 型、7F型、6C型和11A型血清型共占分离株的53.6%。在2013年至2017年期间,3型、8型、12F型、19A 型、22F型和19F型血清型占分离株的51%。在2018 - 2022年期间,8型、3型、11A 型、15A 型、4型和6C型血清型涵盖了55.5%的病例。共有5株(1.6%)对青霉素耐药,64株(20.4%)对红霉素耐药,11株(3.5%)对左氧氟沙星耐药。MIC50和MIC90水平随时间保持稳定。

结论

使用具有不同血清型覆盖范围的结合疫苗导致了疫苗涵盖血清型的减少和未涵盖血清型的增加。尽管有这些变化,但对红霉素和左氧氟沙星的总体抗菌药敏模式保持相对稳定。对青霉素的耐药性较低,在最后一个研究期间未发现此类耐药菌株。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4b/10710669/8aab47cd828d/revespquimioter-36-597-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4b/10710669/eaa02a493fdd/revespquimioter-36-597-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4b/10710669/8aab47cd828d/revespquimioter-36-597-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4b/10710669/eaa02a493fdd/revespquimioter-36-597-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ab4b/10710669/8aab47cd828d/revespquimioter-36-597-g002.jpg

相似文献

1
[Evolution of the serotypes causing invasive pneumococcal disease along 2008-2022 in a Level 2 Public Hospital of the Madrid Region, in relation to their inclusion in different conjugate vaccines].[2008年至2022年期间,马德里地区一家二级公立医院中引起侵袭性肺炎球菌疾病的血清型演变情况,及其与不同结合疫苗纳入情况的关系]
Rev Esp Quimioter. 2023 Dec;36(6):597-603. doi: 10.37201/req/034.2023. Epub 2023 Oct 24.
2
Serotype Distribution and Antimicrobial Resistance of Causing Invasive Pneumococcal Disease in Korea Between 2017 and 2019 After Introduction of the 13-Valent Pneumococcal Conjugate Vaccine.2017 至 2019 年韩国 13 价肺炎球菌结合疫苗引入后,导致侵袭性肺炎球菌病的血清型分布和抗菌药物耐药性
Ann Lab Med. 2023 Jan 1;43(1):45-54. doi: 10.3343/alm.2023.43.1.45. Epub 2022 Sep 1.
3
[Pneumococcal bacteremia in adult patients at a hospital in Madrid: serotypes and susceptibility].[马德里一家医院成年患者的肺炎球菌菌血症:血清型及药敏情况]
Rev Esp Quimioter. 2012 Jun;25(2):155-60.
4
Changes in the Serotype Distribution among Antibiotic Resistant Carriage Streptococcus pneumoniae Isolates in Children after the Introduction of the Extended-Valency Pneumococcal Conjugate Vaccine.引入多价肺炎球菌结合疫苗后儿童抗生素耐药性携带肺炎链球菌分离株血清型分布的变化。
J Korean Med Sci. 2017 Sep;32(9):1431-1439. doi: 10.3346/jkms.2017.32.9.1431.
5
Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016.2011 年至 2016 年中国 17 个城市肺炎链球菌分离株的血清型分布和抗生素耐药性。
BMC Infect Dis. 2017 Dec 29;17(1):804. doi: 10.1186/s12879-017-2880-0.
6
Serotype distribution and antimicrobial susceptibility pattern in children≤5years with invasive pneumococcal disease in India - A systematic review.印度5岁及以下侵袭性肺炎球菌疾病患儿的血清型分布及抗菌药物敏感性模式——一项系统评价
Vaccine. 2017 Aug 16;35(35 Pt B):4501-4509. doi: 10.1016/j.vaccine.2017.06.079. Epub 2017 Jul 12.
7
Molecular characterization of predominant Streptococcus pneumoniae serotypes causing invasive infections in Canada: the SAVE study, 2011-15.加拿大侵袭性感染中主要流行的肺炎链球菌血清型的分子特征:SAVE 研究,2011-2015 年。
J Antimicrob Chemother. 2018 Jul 1;73(suppl_7):vii20-vii31. doi: 10.1093/jac/dky157.
8
Serotype distribution and susceptibility to penicillin and erythromycin among noninvasive or colonization isolates of Streptococcus pneumoniae in northern Japan: a cross-sectional study in the pre-PCV7 routine immunization period.日本北部肺炎链球菌非侵袭性或定植菌株的血清型分布及对青霉素和红霉素的敏感性:PCV7常规免疫接种前时期的横断面研究
Microb Drug Resist. 2014 Oct;20(5):456-65. doi: 10.1089/mdr.2013.0196. Epub 2014 Apr 25.
9
Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: an overview from Kuwait.肺炎球菌结合疫苗对侵袭性肺炎球菌病负担和肺炎链球菌分离株血清型分布的影响:科威特的综述。
Vaccine. 2012 Dec 31;30 Suppl 6:G37-40. doi: 10.1016/j.vaccine.2012.10.061.
10
Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: a 10-year study.在突尼斯儿科人群中,结合型肺炎球菌疫苗的非易感性趋势和血清型覆盖率:一项 10 年研究。
Vaccine. 2012 Dec 31;30 Suppl 6:G18-24. doi: 10.1016/j.vaccine.2012.07.017.

本文引用的文献

1
Evolution of Antimicrobial Susceptibility to Penicillin in Invasive Strains of during 2007-2021 in Madrid, Spain.2007年至2021年期间西班牙马德里侵袭性菌株对青霉素的抗菌敏感性演变。
Antibiotics (Basel). 2023 Feb 1;12(2):289. doi: 10.3390/antibiotics12020289.
2
The remarkable history of pneumococcal vaccination: an ongoing challenge.肺炎球菌疫苗的非凡历史:一项持续的挑战。
Pneumonia (Nathan). 2022 Sep 25;14(1):5. doi: 10.1186/s41479-022-00097-y.
3
Effect of pneumococcal conjugate vaccines and SARS-CoV-2 on antimicrobial resistance and the emergence of Streptococcus pneumoniae serotypes with reduced susceptibility in Spain, 2004-20: a national surveillance study.
2004-20 年期间西班牙肺炎球菌结合疫苗和 SARS-CoV-2 对抗菌药物耐药性及低敏性肺炎链球菌血清型出现的影响:一项全国性监测研究。
Lancet Microbe. 2022 Oct;3(10):e744-e752. doi: 10.1016/S2666-5247(22)00127-6. Epub 2022 Aug 3.
4
20-Valent Pneumococcal Conjugate Vaccine: A Review of Its Use in Adults.20价肺炎球菌结合疫苗:成人使用情况综述
Drugs. 2022 Jun;82(9):989-999. doi: 10.1007/s40265-022-01733-z. Epub 2022 Jul 6.
5
Phase 1/2 study of a novel 24-valent pneumococcal vaccine in healthy adults aged 18 to 64 years and in older adults aged 65 to 85 years.一项新型 24 价肺炎球菌疫苗在 18 至 64 岁健康成年人和 65 至 85 岁老年人中的 1/2 期研究。
Vaccine. 2022 Jul 29;40(31):4190-4198. doi: 10.1016/j.vaccine.2022.05.079. Epub 2022 Jun 9.
6
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices - United States, 2022.美国成人中 15 价肺炎球菌结合疫苗和 20 价肺炎球菌结合疫苗的使用:免疫实践咨询委员会更新的建议-美国,2022 年。
MMWR Morb Mortal Wkly Rep. 2022 Jan 28;71(4):109-117. doi: 10.15585/mmwr.mm7104a1.
7
A national longitudinal study evaluating the activity of cefditoren and other antibiotics against non-susceptible Streptococcus pneumoniae strains during the period 2004-20 in Spain.一项在西班牙评估 2004-20 年期间头孢地尼和其他抗生素对非敏感肺炎链球菌菌株活性的全国性纵向研究。
J Antimicrob Chemother. 2022 Mar 31;77(4):1045-1051. doi: 10.1093/jac/dkab482.
8
Lot-to-lot consistency, safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in healthy adults aged ≥50 years: A randomized phase 3 trial (PNEU-TRUE).V114,一种 15 价肺炎球菌结合疫苗,在≥50 岁健康成年人中的批间一致性、安全性、耐受性和免疫原性:一项随机 3 期试验(PNEU-TRUE)。
Vaccine. 2022 Feb 23;40(9):1342-1351. doi: 10.1016/j.vaccine.2021.12.067. Epub 2022 Jan 14.
9
A phase 3 trial of safety, tolerability, and immunogenicity of V114, 15-valent pneumococcal conjugate vaccine, compared with 13-valent pneumococcal conjugate vaccine in adults 50 years of age and older (PNEU-AGE).一项关于 V114(15 价肺炎球菌结合疫苗)与 13 价肺炎球菌结合疫苗在 50 岁及以上成年人中的安全性、耐受性和免疫原性的 3 期临床试验(PNEU-AGE)。
Vaccine. 2022 Jan 3;40(1):162-172. doi: 10.1016/j.vaccine.2021.08.049. Epub 2021 Sep 8.
10
A historical perspective of MDR invasive pneumococcal disease in Spanish adults.西班牙成人耐多药侵袭性肺炎球菌病的历史观察。
J Antimicrob Chemother. 2021 Jan 19;76(2):507-515. doi: 10.1093/jac/dkaa465.